These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 2869673)

  • 1. Acute hemodynamic and metabolic effects of ICI 118,587 (Corwin), a selective partial beta 1 agonist, in patients with dilated cardiomyopathy.
    Bhatia SJ; Swedberg K; Chatterjee K
    Am Heart J; 1986 Apr; 111(4):692-6. PubMed ID: 2869673
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Acute effect of the cardioselective beta-1-partial agonist, Corwin, on ventricular function and myocardial oxygen consumption in patients with dilated cardiomyopathy].
    Amende I; Simon R; Hood WP; Lichtlen PR
    Z Kardiol; 1986 May; 75(5):291-5. PubMed ID: 2874668
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative effects of dobutamine and corwin, a beta 1-adrenergic partial agonist, in experimental left ventricular failure.
    Vik-Mo H; Yasay G; Maroko PR; Ribeiro LG
    J Cardiovasc Pharmacol; 1985; 7(4):784-90. PubMed ID: 2410722
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Role of adrenergic beta receptor partial agonists in left ventricular failure of ischemic origin. Value of xamoterol (ICI 118,587, Corwin)].
    Rousseau MF; Cheron P; Nannan M; Vincent MF; Lavenne F; Pouleur H
    Ann Med Interne (Paris); 1985; 136(3):247-50. PubMed ID: 2862823
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hemodynamic effects of ICI 118.587 (Corwin) in patients with mild cardiac failure after myocardial infarction.
    Svensson G; Rehnqvist N; Sjögren A; Erhardt L
    J Cardiovasc Pharmacol; 1985; 7(1):97-101. PubMed ID: 2580158
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of the partial beta-1-adrenoceptor agonist xamoterol on hemodynamics and myocardial energetics in patients with idiopathic dilated cardiomyopathy.
    Thierfelder L; Holubarsch C; Hasenfuss G; Heiss HW; Just H
    J Cardiovasc Pharmacol; 1991 Apr; 17(4):593-9. PubMed ID: 1711626
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myocardial energetics in dilated cardiomyopathy.
    Thierfelder L; Holubarsch CH; Hasenfuss G; Just HJ
    Clin Cardiol; 1990 Sep; 13(9):649-54. PubMed ID: 1976466
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hemodynamic effects of Corwin (ICI 118,587), a new cardioselective beta-adenoceptor partial agonist.
    Detry JM; Decoster PM; Brasseur LA
    Eur Heart J; 1983 Aug; 4(8):584-91. PubMed ID: 6139282
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of xamoterol on myocardial energetics in man.
    Sakai O; Fujita M; Sasayama S; Asanoi H; Nakajima H; Yokawa S
    Jpn Circ J; 1988 Feb; 52(2):149-54. PubMed ID: 2896256
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of a cardioselective beta 1 partial agonist (corwin) on left ventricular function and myocardial metabolism in patients with previous myocardial infarction.
    Rousseau MF; Pouleur H; Vincent MF
    Am J Cardiol; 1983 May; 51(8):1267-74. PubMed ID: 6133444
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of xamoterol in failing human myocardium.
    Schwinger RH; Böhm M; Erdmann E
    Eur Heart J; 1990 Apr; 11(4):323-7. PubMed ID: 1970536
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of xamoterol on resting and exercise haemodynamics in patients with chronic heart failure.
    Virk SJ; Davies MK
    Br J Clin Pharmacol; 1989; 28 Suppl 1(Suppl 1):15S-22S. PubMed ID: 2572250
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of combined versus selective adrenergic blockade on left ventricular and systemic hemodynamics, myocardial substrate preference, and regional perfusion in conscious dogs with dilated cardiomyopathy.
    Nikolaidis LA; Poornima I; Parikh P; Magovern M; Shen YT; Shannon RP
    J Am Coll Cardiol; 2006 May; 47(9):1871-81. PubMed ID: 16682315
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical experience of therapy with xamoterol in patients with severe systolic and diastolic dysfunction.
    Pouleur H; Hanet C; Rousseau MF
    Eur Heart J; 1990 Apr; 11 Suppl A():33-8. PubMed ID: 1971587
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of xamoterol on exercise capacity and left ventricular function in angina pectoris and in dilated cardiomyopathy.
    Boström PA; Johansson BW; Lecerof H; Lilja B; Torp A
    Eur Heart J; 1990 Apr; 11 Suppl A():45. PubMed ID: 1971588
    [No Abstract]   [Full Text] [Related]  

  • 16. Acute and chronic effects of xamoterol in idiopathic dilated cardiomyopathy.
    Watanabe K; Hirokawa Y; Suzuki K; Shibata A
    Jpn Heart J; 1988 Sep; 29(5):603-15. PubMed ID: 2975712
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effects of a partial agonist of beta 1 adrenergic receptors (ICI 118,587) on left ventricular performance and metabolism in coronary disease].
    Rousseau MF; Pouleur H; Etienne J; Mengeot P; Cheron P
    Arch Mal Coeur Vaiss; 1984 Jan; 77(1):76-84. PubMed ID: 6142702
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myocardial, coronary, and peripheral effects of xamoterol (ICI 118,587) in open-chest pigs.
    Galiè N; Metalli M; Zannoli R; Binetti G; Branzi A; Magnani B
    Cardiovasc Drugs Ther; 1989 Mar; 3(1):91-7. PubMed ID: 2577281
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Haemodynamic effects of ICI 118,587 in cardiomyopathy.
    Simonsen S
    Br Heart J; 1984 Jun; 51(6):654-7. PubMed ID: 6145436
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antianginal effects of corwin, a new beta-adrenoceptor partial agonist.
    Detry JM; Decoster PM; Buy JJ; Rousseau MF; Brasseur LA
    Am J Cardiol; 1984 Feb; 53(4):439-43. PubMed ID: 6141726
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.